Pricing
Login
Home
Charts
Search
Watchlist
Products

Nectar Lifescience Ltd

NECLIFE
₹9.81-1.70%20 Nov 2026
Reports
Pharma API

Nectar Lifescience Ltd

NECLIFE
₹9.81
-1.70%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹191Cr
Close
Close Price
₹9.81
Industry
Industry
Pharma API
PE
Price To Earnings
—
PS
Price To Sales
109.52
Revenue
Revenue
₹2Cr
Rev Gr TTM
Revenue Growth TTM
-70.85%
PAT Gr TTM
PAT Growth TTM
81.65%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
452441359600510100
Growth YoY
Revenue Growth YoY%
31.413.5-8.8-98.6-100.0-100.0-98.5-87.6-100.012,800.0-91.6-98.6
Expenses
ExpensesCr
41039332060060259287
Operating Profit
Operating ProfitCr
424940-100-11-2-57-27-7
OPM
OPM%
9.311.011.1-10.1-400.0-400.0-16.076.1-4,437.2-6,197.7-66,800.0
Other Income
Other IncomeCr
0111000016314
Interest Expense
Interest ExpenseCr
2524200000030600
Depreciation
DepreciationCr
151515000100000
PBT
PBTCr
2115000-10-32-57-257
Tax
TaxCr
111200000-11-20-94
PAT
PATCr
21368-130-63-17614-68-153
Growth YoY
PAT Growth YoY%
116.9-84.063.2449.0399.4-22,149.2-2,229.0-3,243.082.047.875.6101.5
NPM
NPM%
0.30.10.897.678,400.0-13,00,900.0-1,206.7-24,790.1-5,265.1-3,500.027,200.0
EPS
EPS₹
0.10.00.10.30.3-5.8-2.8-7.80.6-3.4-0.80.1
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
452441359600510100
Growth YoY
Revenue Growth YoY%
31.413.5-8.8-98.6-100.0-100.0-98.5-87.6-100.012,800.0-91.6-98.6
Expenses
ExpensesCr
41039332060060259287
Operating Profit
Operating ProfitCr
424940-100-11-2-57-27-7
OPM
OPM%
9.311.011.1-10.1-400.0-400.0-16.076.1-4,437.2-6,197.7-66,800.0
Other Income
Other IncomeCr
0111000016314
Interest Expense
Interest ExpenseCr
2524200000030600
Depreciation
DepreciationCr
151515000100000
PBT
PBTCr
2115000-10-32-57-257
Tax
TaxCr
111200000-11-20-94
PAT
PATCr
21368-130-63-17614-68-153
Growth YoY
PAT Growth YoY%
116.9-84.063.2449.0399.4-22,149.2-2,229.0-3,243.082.047.875.6101.5
NPM
NPM%
0.30.10.897.678,400.0-13,00,900.0-1,206.7-24,790.1-5,265.1-3,500.027,200.0
EPS
EPS₹
0.10.00.10.30.3-5.8-2.8-7.80.6-3.4-0.80.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,6761,6441,8762,7832,3661,5431,6691,5241,684002
Growth
Revenue Growth%
1.9-1.914.248.3-15.0-34.88.1-8.710.5-100.0-70.8
Expenses
ExpensesCr
1,4371,4191,6402,5192,1471,4341,5101,4711,53306195
Operating Profit
Operating ProfitCr
239224236264220109159531520-61-93
OPM
OPM%
14.313.712.69.59.37.19.53.59.0-5,351.7
Other Income
Other IncomeCr
623664-221143152924
Interest Expense
Interest ExpenseCr
12311711514812611279798703636
Depreciation
DepreciationCr
576264636160575961100
PBT
PBTCr
6467635937-8534-42181-88-106
Tax
TaxCr
101210116-129-18130-31-36
PAT
PATCr
5455524832-7325-2451-57-66
Growth
PAT Growth%
-18.12.0-5.5-8.9-33.2-330.5134.2-196.6120.7-86.0-8,327.781.7
NPM
NPM%
3.23.42.81.71.3-4.81.5-1.60.3-3,812.1
EPS
EPS₹
2.42.52.32.11.4-3.31.1-1.10.2-5.0-13.4-3.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,6761,6441,8762,7832,3661,5431,6691,5241,684002
Growth
Revenue Growth%
1.9-1.914.248.3-15.0-34.88.1-8.710.5-100.0-70.8
Expenses
ExpensesCr
1,4371,4191,6402,5192,1471,4341,5101,4711,53306195
Operating Profit
Operating ProfitCr
239224236264220109159531520-61-93
OPM
OPM%
14.313.712.69.59.37.19.53.59.0-5,351.7
Other Income
Other IncomeCr
623664-221143152924
Interest Expense
Interest ExpenseCr
12311711514812611279798703636
Depreciation
DepreciationCr
576264636160575961100
PBT
PBTCr
6467635937-8534-42181-88-106
Tax
TaxCr
101210116-129-18130-31-36
PAT
PATCr
5455524832-7325-2451-57-66
Growth
PAT Growth%
-18.12.0-5.5-8.9-33.2-330.5134.2-196.6120.7-86.0-8,327.781.7
NPM
NPM%
3.23.42.81.71.3-4.81.5-1.60.3-3,812.1
EPS
EPS₹
2.42.52.32.11.4-3.31.1-1.10.2-5.0-13.4-3.4
Sales CAGR
1 Year-
3 Years-
5 Years-
TTM-71%
Avg. ROCE
1 Year-9%
3 Years-1%
5 Years1%
TTM-12%
CFO / EBITDA
1 Year-
3 Years50%
5 Years91%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
222222222222222222221919
Reserves
ReservesCr
9329841,0361,0831,1141,0401,0651,0421,047934563550
Current Liabilities
Current LiabilitiesCr
1,2401,2791,3091,3001,2481,1871,0048919731,0222623
Non Current Liabilities
Non Current LiabilitiesCr
36229635630024922229923414970139
Total Liabilities
Total LiabilitiesCr
2,5562,5812,7242,7052,6332,4712,3912,1892,1912,047622601
Current Assets
Current AssetsCr
1,4641,4961,6611,6691,6151,2391,3551,2311,2841,238253263
Non Current Assets
Non Current AssetsCr
1,0921,0851,0631,0361,0181,2321,036958907810369338
Total Assets
Total AssetsCr
2,5562,5812,7242,7052,6332,4712,3912,1892,1912,047622601
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
222222222222222222221919
Reserves
ReservesCr
9329841,0361,0831,1141,0401,0651,0421,047934563550
Current Liabilities
Current LiabilitiesCr
1,2401,2791,3091,3001,2481,1871,0048919731,0222623
Non Current Liabilities
Non Current LiabilitiesCr
36229635630024922229923414970139
Total Liabilities
Total LiabilitiesCr
2,5562,5812,7242,7052,6332,4712,3912,1892,1912,047622601
Current Assets
Current AssetsCr
1,4641,4961,6611,6691,6151,2391,3551,2311,2841,238253263
Non Current Assets
Non Current AssetsCr
1,0921,0851,0631,0361,0181,2321,036958907810369338
Total Assets
Total AssetsCr
2,5562,5812,7242,7052,6332,4712,3912,1892,1912,047622601

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
169199652392852195134225169-349
Investing Cash Flow
Investing Cash FlowCr
-77-18-29-26-33-291752-17-421,208
Financing Cash Flow
Financing Cash FlowCr
-89-204-40-201-25211-119-186-205-128-767
Net Cash Flow
Net Cash FlowCr
3-23-41204-802-193
Free Cash Flow
Free Cash FlowCr
8717432204249-10110183195126-341
CFO To PAT
CFO To PAT%
311.2359.2124.7502.6896.4-29.2379.3-552.74,498.224,309.6608.1
CFO To EBITDA
CFO To EBITDA%
70.788.627.690.6129.719.659.9252.1148.3-90,126.6574.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
169199652392852195134225169-349
Investing Cash Flow
Investing Cash FlowCr
-77-18-29-26-33-291752-17-421,208
Financing Cash Flow
Financing Cash FlowCr
-89-204-40-201-25211-119-186-205-128-767
Net Cash Flow
Net Cash FlowCr
3-23-41204-802-193
Free Cash Flow
Free Cash FlowCr
8717432204249-10110183195126-341
CFO To PAT
CFO To PAT%
311.2359.2124.7502.6896.4-29.2379.3-552.74,498.224,309.6608.1
CFO To EBITDA
CFO To EBITDA%
70.788.627.690.6129.719.659.9252.1148.3-90,126.6574.5

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
852789593383222417539356675515181191
Price To Earnings
Price To Earnings
15.714.311.38.17.021.5136.9
Price To Sales
Price To Sales
0.50.50.30.10.10.30.30.20.4109.5
Price To Book
Price To Book
0.90.80.60.30.20.40.50.30.60.50.30.3
EV To EBITDA
EV To EBITDA
7.17.06.14.44.311.38.720.68.5-5,734.8-1.1-0.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.422.019.514.815.616.717.912.617.6
OPM
OPM%
14.313.712.69.59.37.19.53.59.0-5,351.7
NPM
NPM%
3.23.42.81.71.3-4.81.5-1.60.3-3,812.1
ROCE
ROCE%
10.210.39.310.88.71.45.82.06.20.1-8.9-12.2
ROE
ROE%
5.75.54.94.32.8-6.92.3-2.30.50.1-9.8-11.6
ROA
ROA%
2.12.11.91.81.2-3.01.1-1.10.20.0-9.2-11.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
852789593383222417539356675515181191
Price To Earnings
Price To Earnings
15.714.311.38.17.021.5136.9
Price To Sales
Price To Sales
0.50.50.30.10.10.30.30.20.4109.5
Price To Book
Price To Book
0.90.80.60.30.20.40.50.30.60.50.30.3
EV To EBITDA
EV To EBITDA
7.17.06.14.44.311.38.720.68.5-5,734.8-1.1-0.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.422.019.514.815.616.717.912.617.6
OPM
OPM%
14.313.712.69.59.37.19.53.59.0-5,351.7
NPM
NPM%
3.23.42.81.71.3-4.81.5-1.60.3-3,812.1
ROCE
ROCE%
10.210.39.310.88.71.45.82.06.20.1-8.9-12.2
ROE
ROE%
5.75.54.94.32.8-6.92.3-2.30.50.1-9.8-11.6
ROA
ROA%
2.12.11.91.81.2-3.01.1-1.10.20.0-9.2-11.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr5154872571911634437
Close PriceClose₹94.911,610.8058.679.8130.4627.55117.95
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE31.7437.596.7821.609.64
Price To SalesPS1.371.460.65109.520.280.171.24
RevenueRevenueCr377334395258326230
Revenue Growth TTMRev Gr TTM%102.4%-1.0%-70.8%42.4%-2.3%-8.0%
PAT Growth TTMPAT Gr TTM%219.7%-44.7%81.7%35.8%-92.5%-14.1%
Market CapitalizationMkt CapCr5154872571911634437
Close PriceClose₹94.911,610.8058.679.8130.4627.55117.95
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE31.7437.596.7821.609.64
Price To SalesPS1.371.460.65109.520.280.171.24
RevenueRevenueCr377334395258326230
Revenue Growth TTMRev Gr TTM%102.4%-1.0%-70.8%42.4%-2.3%-8.0%
PAT Growth TTMPAT Gr TTM%219.7%-44.7%81.7%35.8%-92.5%-14.1%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews